A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.
Also called NCT02460159
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 135 participants
- Sponsor
- Registry
-
NCT02460159
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02460159. Non-randomized; no masking; primary purpose treatment. Start 2015-06-23 (actual); primary completion 2016-12-22 (actual). Results posted on 2018-01-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)
- Condition
- Hypercholesterolemia
- Condition
- Heterozygous Familial Hypercholesterolemia
- Intervention (Drug)
- EZ 10 mg/Atorva 20 mg FDC
- Intervention (Drug)
- EZ 10 mg/Atorva 10 mg FDC
- Lead sponsor
- Organon and Co
Record details
- Record id
cardio:ct-nct02460159- Content hash
f4040c03e12ac7e86548fe6cf47f78a9d7b46d639af01b2abb941a5b16574fdb